-
Citi Upgrades Rigel Pharmaceuticals (RIGL) to Buy
-
Pre-Open Stock Movers 06/08: Intel Falls on Negative Commentary; Roku Gains on Rumors (more...)
-
Rigel to Participate in Three Upcoming Investor Conferences
-
Rigel to Participate in Citi's 15th Annual BioPharma Virtual Conference
-
Pre-Open Stock Movers 07/13: (BFYT) (ALT) (TSLA) Higher; (CLSN) Lower (more...)
-
New Study Shows Rigel's (RIGL) Tavalisse May Have a Role in Treating COVID-19 Acute Lung Injury - Citi
-
Rigel's CEO to Participate in Panel Discussion at Citi's 14th Annual Biotech Conference
-
Rigel Pharma (RIGL) PT Raised To $9 At Citi After fostamatinib EU Deal Comes Early
-
Rigel Pharmaceuticals (RIGL) PT Lowered to $8 at Citi
-
Rigel Pharma (RIGL) Tavalisse launch is tracking well ahead of expectations - Citi
-
Citi Starts Rigel Pharmaceuticals (RIGL) at Buy
-
Pre-Open Movers 04/03: (MGI) (TSLA) (X) Higher; (LFIN) (SWCH) (RIGL) Lower (more...)
-
Pre-Open Movers 01/31: (DRYS) (MNTA) (SANM) Higher; (UAA) (RRTS) (TEVA) Lower (more...)
-
Notable Analyst Rating Changes 8/1: (OAS) (QGEN) (DLTR) Upgraded; (HOG) (AIV) (CTXS) Downgraded
-
Pre-Open Stock Movers 03/09: (ATSG) (BUFF) (BETR) Higher; (STEM) (ZAGG) (DSX) Lower (more...)
-
Notable Analyst Rating Changes 3/31: (DHI) (TEVA) (CNDO) Upgraded; (SLB) (DB) (WPT) Downgraded
-
Notable 52-Week Highs and Lows of the Day 08/26: (TSLA) (DDD) (QIHU) High; (NES) (RIGL) Low
-
Pre-Open Stock Movers 8/26: (TMS) (QIHU) (ONXX) Higher; (RIGL) (NES) (STNG) Lower (more...)
-
Notable Analyst Rating Changes 06/04: (SDRL) (ALTR) (TOL) Upgraded; (PVH) (RIGL) (CP) Downgraded
-
Notable 52-Week Highs and Lows of the Day 05/22: (MNKD) (CLNT) (BMY) High; (RAX) (RIGL) (CYCC) Low
-
Notable 52-Week Highs and Lows of the Day 12/13: (CVS) (INFI) (CLSN) High; (RIGL) Low
-
Citi Downgrades Rigel Pharmaceuticals (RIGL) to Neutral
-
Rigel (RIGL) Affirms Pricing 13.7M Offering at $9.50/Share
-
Pre-Open Movers 10/03: (SRPT) (ITMN) (BBY) Higher; (XRTX) (ATRS) (SPN) Lower (more...)
-
Rigel Pharma (RIGL) Announces Common Offering
-
Citi Upgrades Rigel Pharmaceuticals (RIGL) to Buy
-
Notable Analyst Rating Changes 09/29: (OKE) (FTI) (QGEN) Upgraded; (AMD) (MIPS) (DVA) Downgraded
-
Notable Analyst Rating Changes 06/11: SQNM, SVVS, BMY, X Upgraded; LGF, AGU, WAG, THO Downgraded
-
Citi Downgrades Rigel Pharmaceuticals (RIGL) to Hold
-
Barclays Gets Bullish On US Biotechnology Sector (BBH)
-
Citi Initiates Coverage on Rigel (RIGL) with a Buy

